Company Filing History:
Years Active: 2016-2018
Title: The Innovations of Benjamin Koziner
Introduction
Benjamin Koziner is a notable inventor based in Buenos Aires, Argentina. He has made significant contributions to the field of autologous cell therapy, holding a total of 3 patents. His work focuses on methods for expanding mesenchymal cells derived from autologous bone marrow, which have promising applications in clinical settings.
Latest Patents
Koziner's latest patents include a method for preparing autologous cells and methods of use for therapy. This method involves expanding mesenchymal cells derived from autologous bone marrow in autologous culture medium. It is designed for use in a clinical setting and includes a business method for performing such expansions as a service for patients in the future. Additionally, he has developed a diagnostic kit for autologous cell therapy, which helps determine whether a patient will respond to the treatment. This kit comprises a system for detecting gene and protein expression, utilizing at least two isolated DNA molecules that detect the expression of genes differentially expressed in the patient's tissue.
Career Highlights
Koziner is currently associated with Biocardia, Inc., where he continues to innovate in the field of cell therapy. His work is pivotal in advancing therapeutic options for patients requiring autologous cell treatments.
Collaborations
Some of his notable coworkers include Didier Rouy and Peter A. Atlman, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Benjamin Koziner's contributions to the field of autologous cell therapy are significant and impactful. His innovative methods and patents pave the way for future advancements in medical treatments.